NN

Nimisha Nandan

Active Director Designated Partner DIN 08517036
DIN 08517036 First appointment Jul 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nimisha Nandan

Data last updated:

Nimisha Nandan is a Designated Partner at Orlant Pharmaceuticals Llp (since 2019). The company operates in Business Services.

DIN 08517036
Primary Designation Designated Partner
Industry Business Services
First Appointment 22 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Jul 20192019Active

Board colleagues of Nimisha Nandan

NameDINCompanyDesignation
Kumaran Janaki Renjith Babu08514320Orlant Pharmaceuticals LlpDesignated Partner
Padathil Rejeeshbabu08515680Orlant Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Orlant Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Nimisha Nandan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimisha Nandan

Nimisha Nandan currently holds 1 directorship: Orlant Pharmaceuticals Llp (Designated Partner, since 22 Jul 2019).

Nimisha Nandan was first appointed on 22 Jul 2019 as Designated Partner at Orlant Pharmaceuticals Llp.

The current boards of Nimisha Nandan's companies include Kumaran Janaki Renjith Babu (Orlant Pharmaceuticals Llp), Padathil Rejeeshbabu (Orlant Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available